- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 78.66M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 79.2M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 86.9M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $22M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $166M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $139M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $185M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $147M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $167M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $676M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $803M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.05B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.22B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.21B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.28B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.37B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.46B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.66 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.94 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.68 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.97 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $237M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $217M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $67M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $65M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $130M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $170M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $194M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $211M |
| Revenue | Q1 2026 · Mar 31, 2026 | $790M |
| Revenue | Q1 2026 · Mar 31, 2025 | $774M |